Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01787559
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
CO4 | 2,4-DIAMINO-5-METHYL-6-[(3,4,5- TRIMETHOXY-N-METHYLANILINO)METHYL]PYRIDO[2,3- D]PYRIMIDINE | A | 1PD8 | 0.73 | |
CO4 | 2,4-DIAMINO-5-METHYL-6-[(3,4,5- TRIMETHOXY-N-METHYLANILINO)METHYL]PYRIDO[2,3- D]PYRIMIDINE | A | 1PD9 | 0.73 | |
MT3 | 2-benzyl-5-{4-[(6,7-dimethoxyquinolin- 4-yl)oxy]-3-fluorophenyl}-3-methylpyrimidin- 4(3H)-one | A,B | 3EFJ | 0.73 | |
RPF | 1-{4-[3-(2-METHOXY-BENZYLOXY)-PROPOXY]- PHENYL}-6-(1,2,,3,4-TETRAHYDRO- QUINOLIN-7-YLOXYMETHYL)-PIPERAZIN- 2-ONE | A,B | 2BKT | 0.72 | |
380 | (2R)-2-({4-[AMINO(IMINO)METHYL]PHENYL}AMINO)- N-BENZYL-2-(3,4-DIMETHOXYPHENYL)ACETAMIDE | H,L | 1W2K | 0.73 | |
ROS | N,N'-TETRAMETHYL-ROSAMINE | A | 1F1T | 0.71 | |
ZD6 | 4-BROMO-2-FLUORO-N-[(4E)-6-METHOXY- 7-[(1-METHYLPIPERIDIN-4-YL)METHOXY]QUINAZOLIN- 4(1H)-YLIDENE]ANILINE | A | 2IVU | 0.76 | |
2RL | N-(4-CHLOROPHENYL)-7-[(6,7-DIMETHOXYQUINOLIN- 4-YL)OXY]-2,3-DIHYDRO-1,4-BENZOXAZINE- 4-CARBOXAMIDE | A | 2RL5 | 0.72 | |
3MR | (4S)-4-(2-AMINO-6-PHENOXYQUINAZOLIN- 3(4H)-YL)-N,4-DICYCLOHEXYL-N-METHYLBUTANAMIDE | A | 2Q15 | 0.7 | |
DTQ | 4-[3-HYDROXYANILINO]-6,7-DIMETHOXYQUINAZOLINE | A | 1DI8 | 0.71 | |
TMQ | TRIMETREXATE | A,B,C,D | 3CLB | 0.75 | |
TMQ | TRIMETREXATE | A | 1BZF | 0.75 | |
TMQ | TRIMETREXATE | A,B,C,D | 3HBB | 0.75 | |
DTM | 2,4-DIAMINO-6-[N-(3',4',5'-TRIMETHOXYBENZYL)- N-METHYLAMINO]PYRIDO[2,3-D]PYRIMIDINE | A | 1MVS | 0.71 | |
DTM | 2,4-DIAMINO-6-[N-(3',4',5'-TRIMETHOXYBENZYL)- N-METHYLAMINO]PYRIDO[2,3-D]PYRIMIDINE | A | 1MVT | 0.71 | |
IRE | 3-CHLORO-4-FLUORO-N-[(4Z)-7-METHOXY- 6-(3-MORPHOLIN-4-YLPROPOXY)QUINAZOLIN- 4(1H)-YLIDENE]ANILINE | A | 2ITZ | 0.76 | |
IRE | 3-CHLORO-4-FLUORO-N-[(4Z)-7-METHOXY- 6-(3-MORPHOLIN-4-YLPROPOXY)QUINAZOLIN- 4(1H)-YLIDENE]ANILINE | A | 2ITO | 0.76 | |
IRE | 3-CHLORO-4-FLUORO-N-[(4Z)-7-METHOXY- 6-(3-MORPHOLIN-4-YLPROPOXY)QUINAZOLIN- 4(1H)-YLIDENE]ANILINE | A | 2ITY | 0.76 | |
T2A | 5-methyl-7-phenyl-N-(3,4,5-trimethoxyphenyl)imidazo[5,1- f][1,2,4]triazin-2-amine | A,C | 3EOC | 0.71 | |
MT4 | 5-{4-[(6,7-dimethoxyquinolin-4- yl)oxy]-3-fluorophenyl}-2-[(4-fluorophenyl)amino]- 3-methylpyrimidin-4(3H)-one | A,B | 3EFK | 0.73 | |
253 | 10,11-dimethoxy-4-methyldibenzo[c,f]- 2,7-naphthyridine-3,6-diamine | A | 2R7B | 0.71 | |
AQ4 | [6,7-BIS(2-METHOXY-ETHOXY)QUINAZOLINE- 4-YL]-(3-ETHYNYLPHENYL)AMINE | A | 1M17 | 0.7 | |
TQD | (2R,6S)-6-{[methyl(3,4,5-trimethoxyphenyl)amino]methyl}- 1,2,5,6,7,8-hexahydroquinazoline- 2,4-diamine | A | 1S3V | 0.84 | |
TQD | (2R,6S)-6-{[methyl(3,4,5-trimethoxyphenyl)amino]methyl}- 1,2,5,6,7,8-hexahydroquinazoline- 2,4-diamine | A | 1S3U | 0.84 | |
771 | 4-(4-BENZYLOXY-2-METHANESULFONYLAMINO- 5-METHOXY-BENZYLAMINO)-BENZAMIDINE | H,L | 1W0Y | 0.73 | |
GVB | (3R,4S)-1-(3,4-DIMETHOXYPHENYL)- 3-(3-METHYLPHENYL)PIPERIDIN-4-AMINE | A,B | 2JID | 0.75 | |
Q4A | N-(1-benzylpiperidin-4-yl)-6,7- dimethoxy-2-(4-methyl-1,4-diazepan- 1-yl)quinazolin-4-amine | A,B | 3FPD | 0.72 | |
GCK | A,B | 1KGK | 0.72 | ||
994 | 4-(2-anilinopyridin-3-yl)-N-(3,4,5- trimethoxyphenyl)-1,3,5-triazin- 2-amine | A | 2P2H | 0.73 |